Altisource Portfolio Solutions is a marketplace and transaction solutions provider for the real estate, mortgage and consumer debt industries. Co. has three reportable segments: mortgage services, which provides asset management services, origination services, insurance services, property valuation services, and default management services; financial services, which provides collection services primarily to debt originators and servicers and customer relationship management services primarily to the utility, insurance and hotel industries; and technology services, which provides software and data analytics solutions and information technology infrastructure management services.

Century Bancorp is a bank holding company. Through its subsidiary, Century Bank and Trust Company, the company provides services to commercial enterprises, state and local governments and agencies, non-profit organizations and individuals. The company also provides securities brokerage services through a program called Investment Services at Century Bank, which is supported by LPL Financial, a third party securities brokerage business. The company grants single-family and multi-family residential loans, commercial and commercial real estate loans, municipal loans, and a variety of consumer loans. In addition, the company provides savings accounts, NOW accounts, demand deposits, time deposits and money market accounts.

CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company's primary focus is on the development of its key product candidate, Neutrolin

Elanco Animal Health is an animal health company. The company groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.

Front Yard Residential is a real estate investment trust and conducts substantially all of its activities through its wholly owned subsidiary, Front Yard Residential, L.P., and its subsidiaries. The company is managed by Altisource Asset Management Corporation (AAMC), which provides the company with personnel to administer the company's business and performs certain of its corporate governance functions. AAMC also provides portfolio management services in connection with the company's acquisition and management of single-family rental properties and the management of its remaining residential mortgage loans and real estate owned properties.

Kodiak Sciences is a clinical stage biopharmaceutical company focusing on therapeutics to treat chronic, high-prevalence retinal diseases. The company's main product candidate is KSI-301, a biologic therapy built with the company's antibody biopolymer conjugate platform, which is designed to maintain drug levels in ocular tissues. KSI-301 is used to treat patients with wet age-related macular degeneration, diabetic retinopathy, including diabetic macular edema, and macular edema due to retinal vein occlusion. The company has applied its antibody biopolymer conjugate platform to develop additional product candidates beyond KSI-301, including KSI-501, its bispecific anti-IL-6/VEGF bioconjugate.

Party City Holdco is a holding company. Through its subsidiaries, the company is a supplier of decorated party goods. The company has two segments: Retail, which operates retail party supply stores in the U.S. and Canada, principally under the names Party City and Halloween City, and it operates e-commerce websites, principally through the domain name PartyCity.com; and Wholesale, which designs, manufactures, contracts for manufacture and distributes party goods, including paper and plastic tableware, metallic and latex balloons, Halloween and other costumes, accessories, novelties and stationery throughout the world.

ServiceSource International is engaged in outsourced customer success and revenue growth solutions. The company's solutions span the lifecycle of its clients' customers, from landing new customers (Co. provides lead generation, inside sales, and outsourced sales operations services), adoption (Co. provides customer onboarding and customer success management services), expansion (Co. provides cross-sell and upsell, warranty conversion, account-based marketing and channel recruitment and enablement) and renewals (Co. provides renewals management services, including the sale of maintenance and support service contracts for the products used by its clients' end-users).

Unifi manufactures and sells recycled and synthetic products made from polyester and nylon primarily to other yarn manufacturers and knitters and weavers that produce yarn and/or fabric for the apparel, hosiery, home furnishings, automotive, industrial and other end-use markets. The company has four segments: Polyester, which sells polyester-based products to other yarn manufacturers, knitters and weavers that produce yarn and/or fabric; Nylon, which sells nylon-based products to knitters and weavers that produce fabric for the apparel and hosiery markets; and Brazil and Asia, which sells polyester-based products to knitters that produce fabric for the apparel markets in South America and in Asia.

Xerox is a workplace technology company. The company's business areas are: Xerox Services, which offerings in this area are Intelligent Workplace Services and a range of Digital Services that utilize the company's software capabilities in Workflow Automation, Personalization and Communication Software, Content Management Solutions, and Digitization Services; Workplace Solutions, which is made up of two product groups, Entry and Mid-Range, which share common technology, manufacturing and product platforms; and Graphic Communications and Production Solutions, which are designed for customers in the graphic communications, in-plant and production print environments with high-volume printing requirements

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.